Perindopril_erbumine: profile and news

Angina Patients Cost Managed Care Over Twice as Much as Coronary ...  May 9, 2006
CV Therapeutics' approved products include Ranexa(TM) (ranolazine extended-release tablets) and ACEON® (perindopril erbumine) Tablets. ... - Yahoo! News (press release)

CV Therapeutics Reports 2006 First Quarter Financial Results  Apr 25, 2006
...quarters of 2005, other expenses incurred to launch Ranexa(TM) (ranolazine extended-release tablets) and co-promote ACEON(R) (perindopril erbumine) Tablets and ... - PR Newswire (press release),

CV Therapeutics Reports Option Grants Under Nasdaq Marketplace ...  Apr 18, 2006
...in connection with its commercialization efforts to promote Ranexa(TM) (ranolazine extended- release tablets) and ACEON(R) (perindopril erbumine) Tablets in ... - PharmaLive.com (press release),